SUFENTANIL CITRATE INJECTION USP
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SUFENTANIL CITRATE INJECTION USP in Canada?
A shortage of SUFENTANIL CITRATE INJECTION USP 50MCG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 13, 2026), but it has not started yet.
Why is SUFENTANIL CITRATE INJECTION USP not available?
The reason the manufacturer reported: Demand increase for the drug.
When will SUFENTANIL CITRATE INJECTION USP be available again?
The manufacturer's estimated resolution date is November 6, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
Estimated Resolution
2026-11-06
~19 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02244147
Strength
50MCG
Dosage Form
SOLUTION
Route
EPIDURAL INTRAVENOUS
Active Ingredient
SUFENTANIL
Tier
Unrated
Last Updated
2026-10-13
Reason for Shortage
Demand increase for the drug.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759